Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is E  [Clear All Filters]
2021
Miao Y, Hu Y, Yi S, Zhang X, Tan N. Establishment of hairy root culture of Rubia yunnanensis Diels: production of Rubiaceae-type cyclopeptides and quinones. J Biotechnol. 2021.
Li C, Cai L, Dong J, Ning S, Zhou J, Wu H, Cui Y, Qin L, Yang X. Establishment of human embryonic stem cell (SKLRMe001-A)carrying Azoospermic factor c (AZFc) deletions. Stem Cell Res. 2021;59:102625.
Bai T, Peng C-Y, Aneas I, Sakabe N, Requena DF, Billstrand C, Nobrega M, Ober C, Parast M, Kessler JA. Establishment of human induced trophoblast stem-like cells from term villous cytotrophoblasts. Stem Cell Res. 2021;56:102507.
Kim J, Koh H, Zhen X, Lee D-S, Ha H-Y, Lee J-H. Establishment of iPSC (KRIBBi001-A) from CD34 group O D-negative bone marrow blood. Stem Cell Res. 2021;51:102199.
Haase A, Kohrn T, Fricke V, Signorini MElena Ricc, Witte M, Göhring G, Gruh I, Martin U. Establishment of MHHi001-A-5, a GCaMP6f and RedStar dual reporter human iPSC line for in vitro and in vivo characterization and in situ tracing of iPSC derivatives. Stem Cell Res. 2021;52:102206.
Kishimoto K, Shimada A, Shinohara H, Takahashi T, Yamada Y, Higuchi Y, Yoneda N, Suemizu H, Kawai K, Kurotaki Y, et al. Establishment of novel common marmoset embryonic stem cell lines under various conditions. Stem Cell Res. 2021;53:102252.
Liu X, Liu Y, Ma Y, Gong Y, Liu Q, Sun W, Guo H. Establishment of patient-specific induced pluripotent stem cell line SDUBMSi009-A from a patient with X-linked Lowe syndrome. Stem Cell Res. 2021;51:102171.
Shang S, Chen K, Cai G, Bai X, Chen X, Li Q. Establishment of PLAFMCi004-A induced pluripotent stem cells derived from PBMCs from a healthy individual. Stem Cell Res. 2021;53:102316.
Cui S, Shang S, Duan S, Wu L, Fu B, Bai X, Li Q, Chen X. Establishment of PLAFMCi005-A induced pluripotent stem cells derived from PBMC from a patient with renal cysts and diabetes syndrome. Stem Cell Res. 2021;55:102485.
Li H, Wang Y, Zhang M, Wang H, Cui A, Zhao J, Ji W, Chen Y-G. Establishment of porcine and monkey colonic organoids for drug toxicity study. Cell Regen. 2021;10(1):32.
Wang G, Gao E, Wu H, Zhang L, Zhu Y, Zhang J, Liu Z. Establishment of the induced pluripotent stem cell line (NCKDi005-A) from a male patient with Alport syndrome carrying a homozygous frameshift mutation in the COL4A4 gene. Stem Cell Res. 2021;58:102628.
He L, Zhang J, Guo D, Tian H, Cao Y, Ji X, Zhan Y. Establishment of the technology of cambial meristematic cells (CMCs) culture from shoots and high expression of FmPHV (PHAVOLUTA) functions in identification and differentiation of CMCs and promoting the shoot regeneration by hypocotyl in Fraxinus mandshu. Plant Physiol Biochem. 2021;160:352-364.
Steventon B, Busby L, Arias AMartinez. Establishment of the vertebrate body plan: Rethinking gastrulation through stem cell models of early embryogenesis. Dev Cell. 2021;56(17):2405-2418.
Ali E, Ferraro RMonica, Guglielmi A, Lanzi G, Masneri S, Piovani G, Mazzoldi ELaura, Pollara L, Valente EMaria, Accorsi P, et al. Establishment of three Joubert syndrome-derived induced pluripotent stem cell (iPSC) lines harbouring compound heterozygous mutations in CC2D2A gene. Stem Cell Res. 2021;54:102430.
Cui K, Zhu Y, Shi Y, Chen T, Wang H, Guo Y, Deng P, Liu H, Shao X, Qin J. Establishment of Trophoblast-Like Tissue Model from Human Pluripotent Stem Cells in Three-Dimensional Culture System. Adv Sci (Weinh). 2021:e2100031.
Chen K, Zhuang Z, Wang Q, Li K, Xu S, Liu M, Zhang K, Wei L, Zhang Y, Lian H, et al. Establishment of TUSMi009-A, an induced pluripotent stem cell (iPSC) line from a 24-year-old Chinese Han patient with gliocytoma. Stem Cell Res. 2021;56:102546.
Liszewska E, Majchrowicz L, Krogulec E, Kotulska K, Kaczmarek L, Kalita K, Dobrzyń A, Jaworski J. Establishment of two hiPSC lines (IIMCBi001-A and IIMCBi002-A) from dermal fibroblasts of healthy donors and characterization of their cell cycle. Stem Cell Res. 2021;52:102225.
Schoger E, Zimmermann W-H, Cyganek L, Zelarayán LCecilia. Establishment of two homozygous CRISPR interference (CRISPRi) knock-in human induced pluripotent stem cell (hiPSC) lines for titratable endogenous gene repression. Stem Cell Res. 2021;55:102473.
Nasimi FSokouti, Zahri S, Ahmadian S, Bagherzadeh A, Yamchi NNazdikbin, Haghighi L, Bedate AMiranda, Khalilzadeh B, Rahbarghazi R, Mahdipour M. Estradiol modulated differentiation and dynamic growth of CD90 spermatogonial stem cells toward Sertoli-like cells. Life Sci. 2021:120041.
Li T, Jiang H, Li Y, Zhao X, Ding H. Estrogen promotes lncRNA H19 expression to regulate osteogenic differentiation of BMSCs and reduce osteoporosis via miR-532-3p/SIRT1 axis. Mol Cell Endocrinol. 2021:111171.
Martin EM, Orlando KA, Yokobori K, Wade PA. The estrogen receptor/GATA3/FOXA1 transcriptional network: lessons learned from breast cancer. Curr Opin Struct Biol. 2021;71:65-70.
Kumar RSani, Goyal N. Estrogens as regulator of hematopoietic stem cell, immune cells and bone biology. Life Sci. 2021:119091.
Gorki V, Walter NSylvia, Chauhan M, Kaur M, Dhingra N, Bagai U, Kaur S. Ethanol extract of Bergenia ciliata (Haw.) Sternb. (rhizome) impedes the propagation of the malaria parasite. J Ethnopharmacol. 2021:114417.
Turner L, Munsie M, Levine AD, Ikonomou L. Ethical issues and public communication in the development of cell-based treatments for COVID-19: Lessons from the pandemic. Stem Cell Reports. 2021.
Zeps N, Lysaght T, Chadwick R, Erler A, Foo R, Giordano S, San Lai P, G Schaefer O, Xafis V, Chew WLeong, et al. Ethics and regulatory considerations for the clinical translation of somatic cell human epigenetic editing. Stem Cell Reports. 2021.

Pages